NIG
LGND icon

NFJ Investment Group’s Ligand Pharmaceuticals LGND Stock Holding History

NFJ Investment Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34M Hold
13,733
– – 0.15% 111
2026
Q1 		$2.74M Buy
13,733
+1,442
+12% +$285K 0.1% 134
2025
Q4 		$2.32M Sell
12,291
-546
-4% -$105K 0.08% 158
2025
Q3 		$2.27M Hold
12,837
– – 0.08% 179
2025
Q2 		$1.46M Sell
12,837
-80
-0.6% -$8.55K 0.05% 225
2025
Q1 		$1.36M Buy
12,917
+1,070
+9% +$121K 0.05% 238
2024
Q4 		$1.27M Buy
+11,847
New +$1.34M 0.04% 240

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NFJ Investment Group's LGND Position: Q2 2026 in Review

NFJ Investment Group held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 13,733 shares worth $4.34M. The position accounts for 0.15% of the portfolio, ranked #111.

NFJ Investment Group first reported a position in LGND in Q4 2024 and has held it in 7 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • NFJ Investment Group held 13,733 shares of Ligand Pharmaceuticals worth $4.34M as of Q2 2026.
  • NFJ Investment Group left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up 0.15% of NFJ Investment Group's portfolio in Q2 2026, its #111 holding.
  • NFJ Investment Group first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on NFJ Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.